Atwood et al. BMC Genomics 2011, 12:14 http://www.biomedcentral.com/1471-2164/12/14 Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J Biol Chem 2001, 276(52):48733-48739. 45. van Koppen C, Meyer zu Heringdorf M, Laser KT, Zhang C, Jakobs KH, Bunemann M, Pott L: Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem 1996, 271(4):2082-2087. 46. Werry TD, Christie MI, Dainty IA, Wilkinson GF, Willars GB: Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells. Br J Pharmacol 2002, 135(5):1199-1208. 47. Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta2- adrenergic receptor to different G proteins by protein kinase A. Nature 1997, 390(6655):88-91. 48. Dautzenberg FM, Higelin J, Teichert U: Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. Eur J Pharmacol 2000, 390(1-2):51-59. 49. Kaupmann K, Bruns C, Hoyer D, Seuwen K, Lubbert H: Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett 1993, 331(1-2):53-59. 50. Kramarenko II, Bunni MA, Morinelli TA, Raymond JR, Garnovskaya MN: Identification of functional bradykinin B(2) receptors endogenously expressed in HEK293 cells. Biochem Pharmacol 2009, 77(2):269-276. 51. Jones SV: m4 muscarinic receptor subtype activates an inwardly rectifying potassium conductance in AtT20 cells. Neurosci Lett 1992, 147(2):125-130. 52. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H: Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 1997, 138(5):1930-1934. 53. Westendorf JM, Schonbrunn A: Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Endocrinology 1985, 116(6):2528-2535. 54. Peeters PJ, Gohlmann HW, Van den Wyngaert I, Swagemakers SM, Bijnens L, Kass SU, Steckler T: Transcriptional response to corticotropin-releasing factor in AtT-20 cells. Mol Pharmacol 2004, 66(5):1083-1092. 55. Clark MA, Korte A, Myers J, Egan RW: High affinity histamine H3 receptors regulate ACTH release by AtT-20 cells. Eur J Pharmacol 1992, 210(1):31-35. 56. Meng J, Ma X, Li M, Jia M, Luo X: Histamine H(4) receptors regulate ACTH release in AtT-20 cells. Eur J Pharmacol 2008, 587(1-3):336-338. 57. Yoshida D, Nomura R, Teramoto A: Signaling Pathway Mediated by CXCR7, an Alternative Chemokine Receptor for Stromal-Cell Derived Factor-1alpha, in AtT20 mouse ACTH-secreting pituitary adenoma cells. J Neuroendocrinol 2009, 21(5):481-488. 58. Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A: Differential changes in GPR55 during microglial cell activation. FEBS Lett 2009, 583(12):2071-2076. 59. Lee JY, Jhun BS, Oh YT, Lee JH, Choe W, Baik HH, Ha J, Yoon KS, Kim SS, Kang I: Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells. Neurosci Lett 2006, 396(1):1-6. 60. Jang MH, Jung SB, Lee MH, Kim CJ, Oh YT, Kang I, Kim J, Kim EH: Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett 2005, 380(1-2):26-31. 61. Su Y, Ganea D, Peng X, Jonakait GM: Galanin down-regulates microglial tumor necrosis factor-alpha production by a post-transcriptional mechanism. J Neuroimmunol 2003, 134(1-2):52-60. 62. Kremlev SG, Roberts RL, Palmer C: Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 2004, 149(1-2):1-9. 63. Lee JK, McCoy MK, Harms AS, Ruhn KA, Gold SJ, Tansey MG: Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response. J Neurosci 2008, 28(34):8517-8528. 64. Hwang SH, Choi YG, Jeong MY, Hong YM, Lee JH, Lim S: Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells. Gene 2009, 443(1-2):83-90. Page 14 of 14 65. Hausmann ON, Hu WH, Keren-Raifman T, Witherow DS, Wang Q, Levay K, Frydel B, V ZS, J RB: Spinal cord injury induces expression of RGS7 in microglia/macrophages in rats. Eur J Neurosci 2002, 15(4):602-612. 66. Yang Y, Hahm E, Kim Y, Kang J, Lee W, Han I, Myung P, Kang H, Park H, Cho D: Regulation of IL-18 expression by CRH in mouse microglial cells. Immunol Lett 2005, 98(2):291-296. 67. Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V, Ragozzino D, Limatola C: Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J Immunol 2008, 180(11):7590-7596. 68. Taylor DL, Jones F, Kubota ES, Pocock JM: Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005, 25(11):2952-2964. 69. Taylor DL, Diemel LT, Pocock JM: Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci 2003, 23(6):2150-2160. 70. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA: Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 1993, 90(16):7656-7660. 71. Hanham CA, Zhao F, Tignor GH: Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. J Virol 1993, 67(1):530-542. 72. Howlett AC, Fleming RM: Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 1984, 26(3):532-538. 73. Roth BL, Beinfeld MC, Howlett AC: Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase. J Neurochem 1984, 42(4):1145-1152. 74. Rice WR, Burton FM, Fiedeldey DT: Cloning and expression of the alveolar type II cell P2u-purinergic receptor. Am J Respir Cell Mol Biol 1995, 12(1):27-32. 75. Amano T, Richelson E, Nirenberg M: Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons- dendrites). Proc Natl Acad Sci USA 1972, 69(1):258-263. 76. Bono H, Yagi K, Kasukawa T, Nikaido I, Tominaga N, Miki R, Mizuno Y, Tomaru Y, Goto H, Nitanda H, et al: Systematic expression profiling of the mouse transcriptome using RIKEN cDNA microarrays. Genome Res 2003, 13(6B):1318-1323. doi:10.1186/1471-2164-12-14 Cite this article as: Atwood et al.: Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 2011 12:14. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit